ADMA Biologics, Inc. ADMA
$12.73
-3.63%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (2 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $16.00
- Implied Upside
- +25.7%
- Price Target Range
- $13.00 – $18.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-05 | Cantor FitzgeraldKristen Kluska |
Maintains | Neutral | $12 → $13 |
| 2026-07-15 | MizuhoAnthony Petrone |
Maintains | Outperform | $20 → $17 |
| 2026-05-07 | Canaccord GenuityGary Nachman |
Maintains | Buy | $21 → $18 |
| 2026-05-07 | MizuhoAnthony Petrone |
Maintains | Outperform | $24 → $20 |
| 2026-04-21 | Canaccord GenuityGary Nachman |
Initiates coverage on | Buy | $21 |
| 2026-04-13 | MizuhoAnthony Petrone |
Maintains | Outperform | $30 → $24 |
| 2026-03-26 | Cantor FitzgeraldKristen Kluska |
Downgrades | Overweight → Neutral | — |
| 2025-05-08 | Raymond JamesElliot Wilbur |
Maintains | Strong buy | $25 → $32 |
| 2025-03-04 | Cantor FitzgeraldKristen Kluska |
Reiterates | Overweight | $25 |
| 2024-11-08 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $18 → $26 |
| 2024-11-08 | Raymond JamesElliot Wilbur |
Maintains | Strong buy | $18 → $25 |
| 2024-10-14 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $18 |
| 2024-09-20 | Cantor FitzgeraldKristen Kluska |
Reiterates | Overweight | $20 |
| 2024-08-12 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $10 → $18 |
| 2024-08-09 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $15 → $20 |
| 2024-07-09 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $10 → $15 |
| 2024-06-20 | MizuhoAnthony Petrone |
Maintains | Buy | $12 → $14 |
| 2024-05-10 | Raymond JamesElliot Wilbur |
Maintains | Strong buy | $8 → $10 |
| 2024-05-10 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $8 → $10 |
| 2024-05-10 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $8 → $10 |
| 2024-05-10 | MizuhoAnthony Petrone |
Maintains | Buy | $10 → $12 |
| 2024-03-26 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $6 → $8 |
| 2024-03-01 | MizuhoAnthony Petrone |
Maintains | Buy | $9 → $10 |
| 2024-02-29 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $7 → $8 |
| 2024-02-29 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $6 |
| 2024-01-22 | MizuhoAnthony Petrone |
Maintains | Buy | $7 → $9 |
| 2024-01-09 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $5 → $6 |
| 2023-12-19 | Cantor FitzgeraldKristen Kluska |
Reiterates | Overweight | $6 |
| 2023-11-17 | HC Wainwright & Co.Raghuram Selvaraju |
Reiterates | Buy | $5 |
| 2023-08-10 | Cantor FitzgeraldKristen Kluska |
Maintains | Overweight | $5 → $6 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $12.73
- Market Cap
- $2.93 billion
- 52-Week Range
- $7.21 – $20.46
- Average Volume
- 3.74 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.